Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

Find Full text
Thumbnail
Fulltext:
207891.pdf
Embargo:
until further notice
Size:
504.3Kb
Format:
PDF
Description:
publisher's version
Publication year
2019
Author(s)
Sluiter, R.L.
Marrewijk, C.J. van
Jong, D.J. de
Scheffer, H.
Guchelaar, H.J.
Derijks, L.J.
Vermeulen, S.H.
Verbeek, A.L.M.
Franke, B.
Wilt, G.J. van der
Kievit, W.
Coenen, M.J.H.
Source
Journal of Crohn's and Colitis, 13, 7, (2019), pp. 838-845
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/207891   https://hdl.handle.net/2066/207891
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.